多西紫杉醇
三阴性乳腺癌
三重阴性
医学
肿瘤科
内科学
癌症研究
乳腺癌
化疗
癌症
作者
Anabel Sorolla,Edina Wang,Tristan D. Clemons,Cameron W. Evans,Janice H. C. Plani-Lam,Emily Golden,Ben Dessauvagie,Andrew David Redfern,K. Swaminathan-Iyer,Pilar Blancafort
标识
DOI:10.1016/j.nano.2019.04.006
摘要
Triple negative breast cancers (TNBC) are aggressive malignancies for which chemotherapy is the only treatment option. Many TNBC acquire chemotherapy resistance, notably docetaxel, which has been associated with the overexpression of transcription factors (TFs), such as ENGRAILED1 (EN1). Here, we have developed a tumor delivery system for docetaxel-PGMA-PAA-nanoparticles and interference peptides designed to specifically inhibit EN1 (EN1-iPeps). To promote tumor specific targeting, we functionalized these nanoparticles with EN1-iPeps engineered with RGD sequences. We found that these peptides reduce cell viability and induce apoptosis in TNBC cells with negligible effects on normal cells (EN1 − ). Moreover, EN1-RGD-iPeps-mediated nanoparticle internalization into breast cancer cells was via integrins and intravenous injection of this nanoformulation increased tumor accumulation. Furthermore, docetaxel nanoparticles functionalized with EN1-RGD-iPeps significantly reduced TNBC growth both in vitro and in vivo without showing toxicity. Our results suggest that this targeted nanoformulation represents a new and safe therapeutic approach for chemoresistant TNBCs.
科研通智能强力驱动
Strongly Powered by AbleSci AI